Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly
Update Conference Call for the first quarter of 2012 on Thursday, April
26, 2012 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M. Bradbury, Amylin's
president and chief executive officer, will lead the call. On the same
date pre-market, Amylin will release financial results for the first
quarter of 2012.
The call will be webcast live through the "Investors" section of
Amylin's corporate website and a recording will be made available
following the close of the call. To access the webcast, please log on to http://www.amylin.com
approximately 15 minutes prior to the call to register, download and
install any necessary audio software. For those without access to the
Internet, the live call may be accessed by phone by calling (888)
989-4344 (U.S./Canada) or (312) 470-7140 (international), participant
passcode number 7994841. A replay of the call will also be available by
phone beginning approximately two hours after the close of the call and
can be accessed at (800) 756-0205 (U.S./Canada) or (203) 369-3002
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of innovative
medicines. Amylin is committed to delivering novel therapies that
transform the way diabetes and other metabolic disorders are treated.
Amylin is headquartered in San Diego, Calif. and has a commercial
manufacturing facility in Ohio. More information on Amylin
Pharmaceuticals is available at www.amylin.com.
Amylin Pharmaceuticals, Inc.